Status:
COMPLETED
Risperidone LA Heathcare Resource Study
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Riverview Hospital
Conditions:
Psychosis
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The primary objective of this pilot study is to evaluate the impact of switching 30 subjects from an existing antipsychotic to risperidone long acting on healthcare resource utilization. The study wil...
Detailed Description
Screening (Week -2 to Week 0; Days -14 to -1) In this phase, the subject is required to be treated with oral risperidone (as their only antipsychotic) for a period of at least 5 days before entering t...
Eligibility Criteria
Inclusion
- Subjects with a diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV criteria.
- Men and women, aged 18-65 years.
- Subjects must be able to give written informed consent.
- Subjects must be inpatients.
- Subjects must have adequate data to assess healthcare resource utilization for the previous 10 months.
- Subjects must have been previously treated with (and tolerated) oral risperidone.
- Results of standard clinical laboratory tests are to be within the laboratory's reference range or, if outside this range, judged by the investigator to be not clinically significant.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00272597
Start Date
September 1 2005
End Date
October 1 2010
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riverview Hospital
Coquitlam, British Columbia, Canada